SCHEMBL14720459

SCHEMBL14720459

CC(=C1CCN(C2CCC2)CC1)c1ccc(CNC2CCCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.46
HRH3 Q9Y5N1 4/20 0.44
POLB P06746 2/20 0.43
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
FABP6 P51161 1/20 0.39
DRD2 P14416 1/20 0.37
DRD1 P21728 1/20 0.37
DRD5 P21918 1/20 0.37
PARP1 P09874 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HPGD P15428 1/20 0.36
ACHE P22303 2/20 0.36
BACE1 P56817 2/20 0.36
CXCR4 P61073 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720722 0.82 KDM2B (0.43) HRH3OPRM1OPRD1OPRK1
SCHEMBL14720596 0.77 HDAC1 (0.53) HDAC1HRH3POLBSMN1; SMN2
SCHEMBL14720460 0.75 HRH3 (0.47) HDAC1HRH3POLBFABP6PARP1
SCHEMBL14730983 0.75 HRH3 (0.43) HDAC1HRH3POLBFABP6ACHE
SCHEMBL14730640 0.75 HRH3 (0.43) HDAC1HRH3POLBFABP6ACHE
SCHEMBL14721114 0.74 SLC18A3 (0.53) HDAC1HRH3POLBFABP6DRD2
SCHEMBL4206550 0.73 ACHE (0.58) HRH3POLBFABP6ACHEBACE1
SCHEMBL14720929 0.72 HRH3 (0.46) HDAC1HRH3POLBFABP6ACHE
SCHEMBL14720750 0.72 HRH3 (0.46) HDAC1HRH3POLBFABP6
SCHEMBL14720484 0.72 ALDH1A1 (0.58) POLBOPRM1OPRD1OPRK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed